Skip to main content

HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile.

Publication ,  Journal Article
Pannullo, AG; Guan, Z; Goldfine, H; Ellermeier, CD
Published in: mBio
April 25, 2023

Clostridioides difficile is a Gram-positive opportunistic pathogen responsible for 250,000 hospital-associated infections, 12,000 hospital-associated deaths, and $1 billion in medical costs in the United States each year. There has been recent interest in using a daptomycin analog, surotomycin, to treat C. difficile infections. Daptomycin interacts with phosphatidylglycerol and lipid II to disrupt the membrane and halt peptidoglycan synthesis. C. difficile has an unusual lipid membrane composition, as it has no phosphatidylserine or phosphatidylethanolamine, and ~50% of its membrane is composed of glycolipids, including the unique C. difficile lipid aminohexosyl-hexosyldiradylglycerol (HNHDRG). We identified a two-component system (TCS), HexRK, that is required for C. difficile resistance to daptomycin. Using transcriptome sequencing (RNA-seq), we found that HexRK regulates expression of hexSDF, a three-gene operon of unknown function. Based on bioinformatic predictions, hexS encodes a monogalactosyldiacylglycerol synthase, hexD encodes a polysaccharide deacetylase, and hexF encodes an MprF-like flippase. Deletion of hexRK leads to a 4-fold decrease in daptomycin MIC, and that deletion of hexSDF leads to an 8- to 16-fold decrease in daptomycin MIC. The ΔhexSDF mutant is also 4-fold less resistant to bacitracin but no other cell wall-active antibiotics. Our data indicate that in the absence of HexSDF, the phospholipid membrane composition is altered. In wild-type (WT) C. difficile, the unique glycolipid HNHDRG makes up ~17% of the lipids in the membrane. However, in a ΔhexSDF mutant, HNHDRG is completely absent. While it is unclear how HNHDRG contributes to daptomycin resistance, the requirement for bacitracin resistance suggests it has a general role in cell membrane biogenesis. IMPORTANCE Clostridioides difficile is a major cause of hospital-acquired diarrhea and represents an urgent concern due to the prevalence of antibiotic resistance and the rate of recurrent infections. Little is understood about C. difficile membrane lipids, but a unique glycolipid, HNHDRG, has been previously identified in C. difficile and, currently, has not been identified in other organisms. Here, we show that HexSDF and HexRK are required for synthesis of HNHDRG and that production of HNHDRG impacts resistance to daptomycin and bacitracin.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

mBio

DOI

EISSN

2150-7511

Publication Date

April 25, 2023

Volume

14

Issue

2

Start / End Page

e0339722

Location

United States

Related Subject Headings

  • Drug Resistance, Bacterial
  • Daptomycin
  • Clostridioides difficile
  • Bacterial Proteins
  • Bacitracin
  • Anti-Bacterial Agents
  • 3207 Medical microbiology
  • 3107 Microbiology
  • 3101 Biochemistry and cell biology
  • 0605 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pannullo, A. G., Guan, Z., Goldfine, H., & Ellermeier, C. D. (2023). HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile. MBio, 14(2), e0339722. https://doi.org/10.1128/mbio.03397-22
Pannullo, Anthony G., Ziqiang Guan, Howard Goldfine, and Craig D. Ellermeier. “HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile.MBio 14, no. 2 (April 25, 2023): e0339722. https://doi.org/10.1128/mbio.03397-22.
Pannullo AG, Guan Z, Goldfine H, Ellermeier CD. HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile. mBio. 2023 Apr 25;14(2):e0339722.
Pannullo, Anthony G., et al. “HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile.MBio, vol. 14, no. 2, Apr. 2023, p. e0339722. Pubmed, doi:10.1128/mbio.03397-22.
Pannullo AG, Guan Z, Goldfine H, Ellermeier CD. HexSDF Is Required for Synthesis of a Novel Glycolipid That Mediates Daptomycin and Bacitracin Resistance in C. difficile. mBio. 2023 Apr 25;14(2):e0339722.

Published In

mBio

DOI

EISSN

2150-7511

Publication Date

April 25, 2023

Volume

14

Issue

2

Start / End Page

e0339722

Location

United States

Related Subject Headings

  • Drug Resistance, Bacterial
  • Daptomycin
  • Clostridioides difficile
  • Bacterial Proteins
  • Bacitracin
  • Anti-Bacterial Agents
  • 3207 Medical microbiology
  • 3107 Microbiology
  • 3101 Biochemistry and cell biology
  • 0605 Microbiology